Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Curvebeam AI Ltd. ( (AU:CVB) ) has shared an announcement.
CurveBeam AI Limited has released its Appendix 4D interim financial statements for the half-year ended 31 December 2025, detailing its financial performance and corporate structure. The filing confirms its governance framework, key executives, and international operational footprint as it continues to report under ASX requirements.
The document highlights the company’s established presence across Australia and the United States, supported by external audit and legal advisers. This interim reporting underscores CurveBeam AI’s ongoing compliance as a listed entity and offers stakeholders updated transparency on its organisational setup, though detailed financial metrics are not included in the provided excerpt.
The most recent analyst rating on (AU:CVB) stock is a Hold with a A$0.15 price target. To see the full list of analyst forecasts on Curvebeam AI Ltd. stock, see the AU:CVB Stock Forecast page.
More about Curvebeam AI Ltd.
CurveBeam AI Limited is an Australian-listed medical technology company focused on advanced imaging solutions, with operations in the U.S. and Europe. The company is headquartered in Melbourne, maintains a U.S. base in Hatfield, Pennsylvania, and is listed on the Australian Securities Exchange under the ticker CVB.
Average Trading Volume: 927,613
Technical Sentiment Signal: Sell
Current Market Cap: A$32.96M
Find detailed analytics on CVB stock on TipRanks’ Stock Analysis page.